Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 15Terminated 4Active not recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

NETWORK 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Breast Neoplasms 31Lymphoma 18Lymphoma, Large B-Cell, Diffuse 17Sarcoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 10Hodgkin Disease 9Lymphoma, Non-Hodgkin 8Recurrence 7Prostatic Neoplasms 7Neoplasms 7Multiple Myeloma 7Burkitt Lymphoma 7Ovarian Neoplasms 6Leukemia 6Lymphoma, B-Cell 5Fallopian Tube Neoplasms 5Cardiotoxicity 5Carcinoma, Hepatocellular 5Urinary Bladder Neoplasms 4Osteosarcoma 4Liver Neoplasms 4Triple Negative Breast Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Colonic Neoplasms 3Waldenstrom Macroglobulinemia 2

Interventions

Gemcitabine 25Cisplatin 19pembrolizumab 11avelumab 10Nivolumab 7Mitomycin 6Carboplatin 6apaziquone 5Paclitaxel 5Vinblastine 4Methotrexate 4Doxorubicin 4Docetaxel 4BCG Vaccine 4vofatamab 3durvalumab 3atezolizumab 3Sunitinib 3Standard of Care 3Sorafenib 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Radiation 3Magnetic Resonance Spectroscopy 3Lapatinib 3Cystectomy 3B701 protein, Human herpesvirus 6 3valrubicin 2rucaparib 2enfortumab vedotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Urinary Bladder Neoplasms × Doxorubicin × Clear all
NCT00005047 2017-06-08

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

SWOG Cancer Research Network

Phase 3 Terminated
521 enrolled 18 charts
Genitourinary

Urinary Bladder Neoplasms

NCT00635726 2015-10-08

Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer

Hellenic Oncology Research Group

Phase 2 Terminated
41 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00516750 2013-07-10

Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin

National Cancer Institute (NCI)

Phase 2 Terminated
100 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00003640 2012-03-06

Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
73 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡